PPT-SPRINT Trial: should we incorporate these results into clinical practice?
Author : tawny-fly | Published Date : 2018-03-17
Eugene Yang MD FACC Clinical Associate Professor of Medicine Medical Director UW Medicine Eastside Specialty Center University of Washington School of Medicine UW
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "SPRINT Trial: should we incorporate thes..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
SPRINT Trial: should we incorporate these results into clinical practice?: Transcript
Eugene Yang MD FACC Clinical Associate Professor of Medicine Medical Director UW Medicine Eastside Specialty Center University of Washington School of Medicine UW MEDICINE WA ACC CVT PROGRAM 2016. You should check with your course provider to find out if your cou rse is eligible for funding and x completing between 11 9 SCQF credits 120 with a non campus based university each academic year and x not receiving support from any other overnment Special Psychiatric Rapid Intervention Team. LCDR Jeffrey Millegan, MD MPH. Overview. Mission and Concept. Composition. Typical Operating Procedures. Activating SPRINT. Mission. To provide rapid deployment of adequately trained mental health professionals in immediate response to fleet requests following a variety of traumatic events. Anh Ninh, College of William and Mary. Outline. Introduction. The Inventory Positioning Problem. Description of the problem. Unique features. Basic of inventory management. Site Selection Problem. 2. Principal Results. Paul K. Whelton, MB, MD, MSc. Chair, SPRINT Steering Committee . Tulane University School of Public Health and Tropical Medicine, and School of Medicine. . For the SPRINT Research Group. NIH Policy & HHS Final Rule. NIH Regional Seminar May 2017. Kristina Elliott, MLS. Information Specialist, ClinicalTrials.gov. National Library of Medicine. https://ClinicalTrials.gov. Agenda. Background on ClinicalTrials.gov. Draft. . Legal. ). Thursday, . September. 15 . Agenda. . W. elcome. and . Introductions. Competition. . Jury. Schedules. and . Timetables. Check-in. and . Procedures. The . course. Post-Race Procedures. 1. . S. print. R. ussell Mosburg, Director M2M. M2M…what’s . NEXT. . now?. Thousands. MILLIONS. Billions. TRILLIONS. 7 trillion wireless devices serving 7 billion people by . 2017. WWRF. Monday. Tuesday. Wednesday. Thursday. Friday. 16. 17. 18. Sprint Planning. (Sprint 1). 19. Daily. standup. 20. Daily. standup. 23. Daily. standup. 24. Daily. standup. 25. Daily. standup. Backlog. Presented By: Group / Team Name. Agenda. Overview of . Sprint XX. Objectives / Scope. . Sprint Accomplishments. . Blockers / Impediments . . Demo. . Planned Activities for . Sprint XX. . . . . Overview: . x0000x0000 x/Attxachexd /xBottxom x/BBoxx 7x2 21x036x 75 x368x04 x/Subxtypex /Foxoterx /Tyxpe /xPagixnatixon 0x/Attxachexd /xBottxom x/BBoxx 7x2 21x036x 75 x368x04 x/Subxtypex /Foxoterx /Tyxpe /xPagix J from clinical trials Signatories on 18 May 2017 The Canadian Institutes of Health Research (CIHR) (joined on 28 October 2020) Health Research Council of New Zealand (joined on 27 July 2020) Euro created . by Kevin Schenk, BS in Computer Science, Purdue University, 2012.. Scrum. 1. Scrum Framework. 2. Scrum Framework. 3. Product Owner. Defines . the features of the product. Decides . on release date and content. Mary Kay Koenig, MD. Associate Vice Chair for Clinical Research. Co-Director for the Tuberous Sclerosis Center of Excellence. Department of Pediatrics. Division of Child & Adolescent Neurology. University of Texas McGovern Medical School. What do we need more evidence on?. There is a need for evidence and data in relation to Open Banking payment success under different value and use cases, as well as data identifying reasons behind payments not going through. What metrics and data in relation to payment success should be collected? Who should provide this data – Banks / TPPs / Both? How should this be operationalised, including who should take this forward, in the short-term and on an ongoing basis as open banking+ develops? Should this insight be shared across ecosystem and what is the best way to do this?.
Download Document
Here is the link to download the presentation.
"SPRINT Trial: should we incorporate these results into clinical practice?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents